Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (351-360 of 446) with videos related to

Pageof 45
Sort By:
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
American Journal of Hematology|March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosisNidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood Advances|February 17, 2021
Prognostic restaging after treatment initiation in patients with AL amyloidosisNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Blood Advances|October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
Leukemia|September 19, 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chainsS Sidana, N Tandon, A Dispenzieri, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Blood Cancer Journal|August 30, 2020
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myelomaAshley Paquin, Alissa Visram, Shaji K Kumar, et al.
Pageof 45

Showing results (351-360 of 446) with videos related to

Sort By:
Pageof 45
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
American Journal of Hematology|March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosisNidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood Advances|February 17, 2021
Prognostic restaging after treatment initiation in patients with AL amyloidosisNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Blood Advances|October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
Leukemia|September 19, 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chainsS Sidana, N Tandon, A Dispenzieri, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Blood Cancer Journal|August 30, 2020
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myelomaAshley Paquin, Alissa Visram, Shaji K Kumar, et al.
Pageof 45